Literature DB >> 3310069

Evidence that lowering serum lipids favourably influences coronary heart disease.

G R Thompson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3310069

Source DB:  PubMed          Journal:  Q J Med        ISSN： 0033-5622


× No keyword cloud information.
  5 in total

Review 1.  Specific lipid lowering therapy in the management of diabetes.

Authors:  P N Durrington
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 2.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

Review 3.  Borderline hypercholesterolaemia: when to introduce drugs.

Authors:  D Bhatnagar; P N Durrington
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 4.  Clinical consequences of hyperlipidaemia.

Authors:  G R Thompson
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 5.  A neonatal screening approach to the detection of familial hypercholesterolaemia and family-based coronary prevention.

Authors:  D E Wilcken; B L Blades; N P Dudman
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.